New York State Common Retirement Fund Lyell Immunopharma, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2025	BUY	$1.13 - $1.88 $57,927 - $96,374	51,263 New	51,263 $70,000
Q2 2024 Oct 08, 2025	BUY	$1.3 - $3.01 $66,641 - $154,301	51,263 New	51,263 $74,000
Q2 2024 Jul 31, 2024	BUY	$1.3 - $3.01 $1,596 - $3,696	1,228 Added 2.45%	51,263 $74,000
Q1 2024 Oct 08, 2025	BUY	$1.71 - $3.07 $85,559 - $153,607	50,035 New	50,035 $111,000
Q1 2024 May 07, 2024	SELL	$1.71 - $3.07 $2,128 - $3,822	-1,245 Reduced 2.43%	50,035 $112,000

Q4 2023 Oct 08, 2025	BUY	$1.39 - $2.35 $71,279 - $120,508	51,280 New	51,280 $99,000
Q4 2023 Feb 01, 2024	SELL	$1.39 - $2.35 $483 - $817	-348 Reduced 0.67%	51,280 $99,000
Q3 2023 Oct 08, 2025	BUY	$1.45 - $3.35 $74,860 - $172,953	51,628 New	51,628 $75,000
Q3 2023 Nov 07, 2023	BUY	$1.45 - $3.35 $755 - $1,745	521 Added 1.02%	51,628 $76,000
Q2 2023 Oct 08, 2025	BUY	$1.89 - $3.86 $96,592 - $197,273	51,107 New	51,107 $162,000
Q2 2023 Aug 07, 2023	SELL	$1.89 - $3.86 $74,099 - $151,335	-39,206 Reduced 43.41%	51,107 $163,000
Q1 2023 Oct 08, 2025	SELL	$1.97 - $3.58 $54,039 - $98,202	-27,431 Reduced 23.3%	90,313 $213,000
Q1 2023 May 02, 2023	SELL	$1.97 - $3.58 $54,039 - $98,202	-27,431 Reduced 23.3%	90,313 $213,000
Q4 2022 Oct 08, 2025	BUY	$2.78 - $8.09 $327,328 - $952,548	117,744 New	117,744 $408,000
Q4 2022 Jan 30, 2023	SELL	$2.78 - $8.09 $133 - $388	-48 Reduced 0.04%	117,744 $409,000
Q3 2022 Nov 08, 2022	BUY	$5.54 - $8.27 $44,597 - $66,573	8,050 Added 7.34%	117,792 $863,000
Q2 2022 Aug 04, 2022	BUY	$3.68 - $6.8 $3,083 - $5,698	838 Added 0.77%	109,742 $716,000
Q1 2022 May 05, 2022	BUY	$5.05 - $7.7 $479,750 - $731,500	95,000 Added 683.26%	108,904 $550,000
Q4 2021 Feb 02, 2022	BUY	$7.13 - $15.19 $28,548 - $60,820	4,004 Added 40.44%	13,904 $108,000
Q3 2021 Nov 02, 2021	BUY	$11.0 - $17.95 $108,900 - $177,705	9,900 New	9,900 $147,000

Others Institutions Holding LYEL

# of Institutions

Shares Held

37.4M

Call Options Held

Put Options Held

Apoletto LTD Washington, DC

15.1M
Shares

$256 Million
42.56% of portfolio
Black Rock Inc. New York, NY

13.5M
Shares

$228 Million
0.0% of portfolio
Wu Xi App Tec Co., Ltd. Shanghai, F4

7.39M
Shares

$125 Million
53.56% of portfolio
Nuveen Asset Management, LLC Chicago, IL

641K
Shares

$10.9 Million
0.0% of portfolio
Decheng Capital LLC Menlo Park, CA

595K
Shares

$10.1 Million
1.69% of portfolio

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $4.2B
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account